Dr. VANI VATHSALA ATLURI | Machine Learning | Best Researcher Award

Professor and HOD | CVR College of Engineering | India

Dr. A. Vani Vathsala is a distinguished academician and researcher in the field of Computer Science and Engineering, currently serving as a Professor and Head of the Department of Computer Science and Engineering at CVR College of Engineering, Hyderabad. With a rich background spanning both academia and industry, including a foundational professional stint at Tata Consultancy Services, Dr. Vathsala has built a career marked by innovation, leadership, and impactful research. She holds a Ph.D. in Computer Science from the University of Hyderabad, preceded by a Master of Technology in Computer Science from the same university and a Bachelor’s degree in Computer Science and Engineering from Nagarjuna University. Her research portfolio reflects expertise in artificial intelligence, cloud computing, machine learning, data security, and sustainable computing systems. She has published extensively in Scopus and SCI-indexed journals, contributing to emerging technologies that bridge healthcare, security, and IoT-driven solutions. Her notable publications include Early Diagnosis for the Bacterial Infections for the Patients under the Medical Intervention of Automated Peritoneal Dialysis Using Machine Learning Techniques, A Cloud Integrity Verification and Validation Model Using Double Token Key Distribution Model, Energy-Efficient and Sustainable Cluster-Based Routing in IoT-Based WSNs Using Metaheuristic Optimization, and Enhanced Real-Time Surveillance and Suspect Identification Using CNN-LSTM Based Body Language Analysis.

Profile: Google Scholar

Featured Publications:

Vathsala, A. V., & Mohanty, H. (2014). A survey on checkpointing web services. Proceedings of the 6th International Workshop on Principles of Engineering,

Vathsala, A. V., & Mohanty, H. (2012). Using HMM for predicting response time of web services. Proceedings of the CUBE International Information Technology Conference, 520–525,

Atluri, V. V., & Mohanty, H. (2014). Web service response time prediction using HMM and Bayesian network. In Intelligent Computing, Communication and Devices: Proceedings of ICCD 2014,

Swathi, V., Kumar, G. S., & Vathsala, A. V. (2023). Cloud service selection system approach based on QoS model: A systematic review. International Journal on Recent and Innovation Trends in Computing and Communication,

Vathsala, A. V. (2011). Optimal call based checkpointing for orchestrated web services. International Journal of Computer Applications, 975(8887),

Archana, M., Kavitha, S., & Vathsala, A. (2023). Auto deep learning-based automated surveillance technique to recognize the activities in the cyber-physical system. International Journal on Recent and Innovation Trends in Computing and Communication,

Swathi, V., Akhilesh, D., Senthil Kumar, G., & Vathsala, A. V. (2021). Real-time driver distraction detection using OpenCV and machine learning algorithms. In Smart Computing Techniques and Applications: Proceedings of the Fourth International Conference,

Prof. alain R THIERRY | Data Science and Deep Learning | Excellence in Research

Director of Research, INSERM U1194, France

Dr. alain R THIERRY, a distinguished biologist, and cancer researcher, is a Director of Research at INSERM and a key figure at the Institut de Recherche en Cancérologie de Montpellier. With an impressive track record in molecular biology, gene therapy, and cancer research, Dr. alain R THIERRY has held numerous influential positions in academia and the biotechnology sector, including roles at NIH and Georgetown University. A prolific author and scientific leader, they have also founded biotech companies like MedinCell and DiaDx. Dr. alain R THIERRYcontinues to drive innovative therapeutic solutions, recognized by international honors and awards.

Publication Profile

scholar

Education🎓

2003: Habilitation à Diriger les Recherches (HDR) in Biology-Health, Université Montpellier II 1987: CES in Human Biology (Oncology), Faculté de Médecine Paris-Sud 1986: PhD in Biochemistry, Cellular & Molecular Pharmacology, Université Montpellier II 1983: MSc in Cellular & Molecular Biology, Université de Clermont-Ferrand II 1983: Diplôme d’Ingénieur, Université Clermont-Fd II 1982: BSc in Biological Sciences & Technology, Université Clermont-Fd

Professional Experience💼

208-present: Director of Research, INSERM, Institut de Recherche en Cancérologie, Montpellier 2001-2007: Associate Professor, Université Montpellier II2003-2004: Director of R&D, MedinCell SA, Montpellier 1997-2000: Scientific Director, Gene Therapy Dept., Biovector Therapeutics 1992-1996: Scientist, Tumor Cell Biology Lab, NCI/NIH, Bethesda 1992-1994: Adjunct Assistant Professor, Lombardi Cancer Institute, Washington DC 1988-1992: Postdoctoral Fellow, Lombardi Cancer Center, Georgetown University

Awards and Honors🏆

1994: Federal Technology Award, NIH, USA ($10,000) 2002: Prix National de l’Innovation, Ministry of Education and Research, Paris (€300,000) 2016: Grand Prix de l’Innovation Thérapeutique, Fondation B. Denys & FRM, Montpellier (€50,000) 2022: Finalist, Prix Innovation Unicancer 2022: Innovation Award, Montpellier Université Excellence

Research Focus 🔬

Molecular Oncology: Pioneer in understanding the molecular pathways of cancer and therapeutic gene delivery Gene Therapy: Focus on targeted gene therapy to treat cancers, with expertise in vectors and delivery systems Circulating DNA: Breakthrough research in non-invasive biomarkers for early cancer detection
Therapeutics Innovation: Key developer of novel therapeutic strategies, including drug delivery systems and cancer diagnostics
Collaborative Research: Strong interdisciplinary collaborations in biotechnology and cancer research

Publication Top Notes

Origins, structures, and functions of circulating DNA in oncology
AR Thierry, S El Messaoudi, PB Gahan, P Anker, M Stroun
Cancer and Metastasis Reviews, 2016 | 812 citations
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
AR Thierry, F Mouliere, S El Messaoudi, C Mollevi, E Lopez-Crapez
Nature Medicine, 2014 | 735 citations
Nomenclature for synthetic gene delivery systems
PL Felgner, Y Barenholz, JP Behr, SH Cheng, P Cullis, L Huang, AR Thierry
Human Gene Therapy, 1997 | 652 citations
High fragmentation characterizes tumour-derived circulating DNA
F Mouliere, B Robert, E Arnau Peyrotte, M Del Rio, M Ychou, F Molina, AR Thierry
PLOS One, 2011 | 627 citations
Circulating cell-free DNA: preanalytical considerations
S El Messaoudi, F Rolet, F Mouliere, AR Thierry
Clinica Chimica Acta, 2013 | 602 citations

Conclusion:

This individual is highly suitable for the Best Researcher Award. Their long-standing career in oncology research, leadership in both academic and biotech sectors, and recognition through awards place them in an elite category of researchers. Continued engagement in broader interdisciplinary fields and public communication could further elevate their profile. Overall, their qualifications, contributions, and leadership make them a strong candidate for excellence in research awards.

alain R THIERRY | Data Science and Deep Learning | Excellence in Research